Medtronic says a preliminary review of an Edwards Lifesciences patent for the Sapien heart valve by the European Patent Office went its way.
Medtronic (NYSE:MDT) is claiming a win in Europe in its patent row with Edwards Lifesciences (NYSE:EW) over their competing transcatheter aortic valve implants.
The European Patent Office issued a preliminary, non-binding ruling that the Edwards patent at the center of a dispute in Germany is invalid, Medtronic said.
Help employers find you! Check out all the jobs and post your resume.
